Krsnaa Diagnostics Limited — Updates, 12-02-2025: Press Release

Krsnaa Diagnostics Ltd. reported substantial financial growth for Q3 FY2025, with total income rising to ₹1,837 million, marking a 13% year-on-year increase. Revenue from operations reached ₹1,745 million, up 10% from the previous year, while EBITDA surged 39% to ₹466 million, demonstrating strong operational efficiency with a margin improvement to 27%. Profit After Tax also showed impressive growth of 50% year-on-year to ₹194 million, reflecting a net margin of 11%.

Operationally, Krsnaa has expanded its presence with 49 NABL-accredited laboratories and launched retail operations in four states. The company has also set a strategic milestone with a unique financing arrangement for new machinery, which is expected to optimize cash flow. With a 17% revenue growth recorded over the first nine months of FY2025, management remains focused on sustainable growth, expanding into new geographical areas, and enhancing the quality of their services. Positive developments suggest a favorable outlook for continued expansion and profitability, with the company poised to continue leveraging its core competencies in a competitive market.